
Top Lung Cancer Data From ASCO 2024 Should Change Practice “Immediately,” Experts Agree
About this episode
Thoracic oncology was a major focus of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, says Sandip P. Patel, MD, a medical oncologist and professor of medicine at the University of California San Diego. Practice-changing data were presented in both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), Dr. Patel told Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at the Cedars-Sinai Cancer Center in Los Angeles.
Get every episode summarized
Each time Oncology News Central Peer-Spectives publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Oncology News Central Peer-Spectives

Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Oncology News Central Peer-Spectives

Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Oncology News Central Peer-Spectives

“Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Trea...
Oncology News Central Peer-Spectives

“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm...
Oncology News Central Peer-Spectives